Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2018-07-06 Annual Report
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
107年年報及股東會資料 — 2017_3164_20180627F04.pdf
Annual Report Classification · 100% confidence The document is titled as a '年度年報' which translates to 'Annual Report' for the fiscal year 106 (which corresponds to 2017 in the Gregorian calendar). It includes detailed sections such as shareholder reports, company governance, capital and shareholding information, operational overview, and financial overview including five years of financial data and auditor opinions. The length is substantial (15,000 characters) and contains comprehensive financial and operational information typical of a full annual report. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2017
2018-07-06 Chinese
107年年報及股東會資料 — 2018_3164_20180627F02.pdf
Annual Report Classification · 95% confidence The document is a detailed meeting manual for the Annual General Meeting (AGM) of GenMont Biotech Inc. for the year 2017 (ROC year 106). It includes the agenda, reports, and attachments such as the 106年度營業報告書 (Annual Business Report),監察人審查報告 (Supervisors' Review Report),董事會議事規則修訂前後條文對照表 (Board Meeting Rules Amendments), and the 會計師查核報告書及106年度財務報表 (Auditor's Report and 2017 Financial Statements). The presence of the full annual business report, audited financial statements, and detailed financial data indicates this is the full Annual Report document rather than just an announcement or a summary. The document length (15,000 characters) and the inclusion of comprehensive financial and governance information confirm it is not a brief announcement or a certification. Therefore, the document fits the definition of an Annual Report (10-K). FY 2017
2018-07-06 Chinese
107年年報及股東會資料 — 2018_3164_20180627F13.pdf
AGM Information Classification · 95% confidence The document is titled as materials related to the Annual General Meeting (AGM) of GenMont Biotech Inc. It includes agenda items such as reports on the previous fiscal year's business operations, financial statements, remuneration reports, amendments to company bylaws, and other shareholder meeting matters. The date and location of the meeting are specified, and the document contains detailed explanations and attachments referenced as part of the meeting handbook. The content is consistent with presentation and explanatory materials shared during an AGM rather than the full annual report or financial statements themselves. The document length is under 5,000 characters and is clearly an AGM meeting agenda and explanatory materials, fitting the AGM Information category.
2018-07-06 Chinese
107年年報及股東會資料 — 2018_3164_20180627F01.pdf
AGM Information Classification · 100% confidence The document is a detailed notice and related materials for the Annual General Meeting (AGM) of 景岳生物科技股份有限公司 for the year 107 (Taiwan calendar year, corresponding to 2018). It includes information about the meeting date, location, agenda items such as approval of financial statements, dividend distribution, amendments to company articles, proxy voting instructions, and electronic voting details. There is no actual financial data or report content, but rather the meeting notification and proxy forms. The document length is 6747 characters, which is consistent with a full AGM notice and materials rather than a brief announcement. Therefore, this document fits the category of AGM Information (AGM-R).
2018-07-06 Chinese
公告本公司申請股票上櫃轉上市時所出具之承諾事項 暨其後續執行情形
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from a listed company (景岳生物科技股份有限公司) regarding the company's commitments made at the time of applying for stock listing transfer and the subsequent execution status as of the second quarter of 2018. It references compliance with a Taiwan Stock Exchange regulation and provides details about auditor commitments and financial reporting. The document length is short (768 characters) and it is an announcement of compliance and status rather than a full financial report or audit report. It does not contain actual financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-07-03 Chinese
公告本公司107年股東常會重要決議事項
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a short announcement (634 characters) reporting the important resolutions from the company's Annual General Meeting (AGM) held on 107/06/27 (Taiwan calendar year). It lists decisions such as profit distribution, amendments to the articles of incorporation, approval of the business report and financial statements for the previous fiscal year, and other procedural updates. There is no detailed financial data or full report content, only a summary of AGM resolutions. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at general meetings. The document is not the full Annual Report or financial statements, nor is it a presentation or proxy statement. Therefore, the classification is DVA with high confidence.
2018-06-27 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.